Ongoing training and development is key to a happy, motivated sales force and now, the PharmaTimes Sales Awards has a category dedicated to the people who make it happen. More: Be recognised for the part you play in targets being
read moreIf you’re an off-patent drug sitting pretty with no rivals—generic or otherwise—enjoy it while you can. To stir up competition and ease shortages, FDA is looking at importing products approved in other countries but not yet in the U.S. More:
read moreThe FDA has so far approved 11 biosimilars, but only three are currently sold in the U.S. FDA Commissioner Scott Gottlieb, M.D., is now blaming developers of the original reference biologics for the “anemic” biosimilar competition. More: FDA chief Gottlieb
read moreLess than one day after Novartis CEO Vas Narasimhan talked up a potential key approval for lagging breast cancer drug Kisqali, the company has that approval in hand. More: Novartis nabs much-needed new nod for slow-growing breast cancer drug Kisqali
read moreNews of the inaugural Medical & Scientific Excellence Awards has got the industry talking, with a number of entries already received. More: Industry shows support for new Medical & Scientific Excellence Awards Source: News
read morePharmaTimes media is partnering with Bowel Cancer UK and Beating Bowel Cancer to launch a Charity Challenge Award as part of the Communications Team of the Year competition. More: Want to make a difference? Enter the new Charity Challenge Source:
read more© 1994 - 2026 B.M. Pharmaceuticals